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Objective: Health economic arguments have become increasingly important in clinical decision making, especially when
new treatment modalities are introduced. This study reviews the methods used in health economic reports of abdominal
aortic aneurysm (AAA) repair and uses original cost data to study how different methods affect interpretation of results
in terms of cost differences and economic efficiency.
Design: Publications referenced in PubMed from 2003 to 2008 studying cost of AAA repair were reviewed. Original
population-based cost data of AAA repair were analyzed, comparing open (OR) and endovascular repair (EVAR). Means,
medians, and cost distributions were calculated, and differences were analyzed with four different statistical methods.
Results:The review showed a mixture of statistical methods used in AAA treatment cost-comparison studies. Presentation
of cost data and inclusion criteria varied between studies. The analysis of original data showed skewed distribution of cost
data, with large differences between mean and median cost. Although mean values indicated a lower total, perioperative,
and postoperative cost for EVAR, the median values indicated OR was the least costly method. Exclusion of extreme
values lowered mean perioperative cost of OR by 10%, while cost of EVAR was unaffected. Inferential testing of cost
differences by means of four statistical methods showed that P values were highly dependent on test methodology.
Conclusions: Conclusions of health economic reports can be highly dependent on how the data are presented and the
statistical methods that are used. We recommend that cost data be presented as mean values with distributions. Exclusion
of outliers and focus on P values should be avoided. (J Vasc Surg 2010;51:148-54.)Health economics has become increasingly important
in health care decision making during the past decades. In
some countries, health economic evaluation of new medi-
cations and treatment strategies is mandatory before these
are reimbursed within the health care system.1,2 In vascular
surgery, discussions on the health economic benefits or
burdens of new endovascular techniques are common, and
the number of publications in PubMed on cost for vascular
surgical procedures has quadrupled since 1990.
Health economic data pose specific challenges to the
researcher. Cost data are almost always skewed, making it
difficult to use the usual statistical methods to analyze cost
differences between alternative treatment strategies.3 Theme-
dian cost disregards the skewedness of data and thus underes-
timates the effect of seldom but regularly occurring cost-
intensive cases and their effect on the total resources that are
needed over time (Fig 1). Thus, in contrast to other medical
research areas where skewed data are best presented with
median values, mean cost is a more relevant value to the
economic decision maker in a budgeting situation.
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148Several inferential statistical methods exist for comparing
the costs of different treatment strategies, all having their pros
and cons.3-7 Although several publications recommend a pre-
sentation of overall mean cost in health economic evaluations,
statistically comparing data with parametric t test or bootstrap
technique,3,4 there is no consistency in how cost data are
analyzed and reported in the literature. It is common practice
in health economic studies to test the sensitivity of cost-
effectiveness calculations for variables such as cost and mor-
bidity; however, we have not encountered any study that tests
how presentation of data and statistical methods affect inter-
pretation of results.
The aim of this study was to review the methods used
in studies evaluating the cost of abdominal aortic aneu-
rysm (AAA) treatment with open (OR) and endovascular
repair (EVAR) and to compare how different methods
for presentation and analysis of cost data affect the
interpretation of results in terms of cost differences and
economic efficiency. To visualize these differences, orig-
inal data from a previously published study8 that com-
pared the cost of OR with the cost of EVAR to repair
AAA were analyzed with different statistical techniques
encountered in published reports.
METHODS
Review. The PubMed database was searched for arti-
cles published between January 1, 2003, andDecember 31,
2008. The Medical Subject Heading (MeSH) criteria were
used to identify articles with MeSH code “aortic aneurysm,
abdominal/economics.” To focus on publications con-
cerning the cost of AAA repair, articles regarding cost of
screening (with MeSH code “mass screening”) were ex-
cluded. The 37 articles that remained were reviewed by the
nipu
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Volume 51, Number 1 Mani et al 149primary author (K. M.). All articles that included a compar-
ison of the cost of AAA repair between OR and EVARwere
scrutinized to identify how cost data had been analyzed
statistically and what data were presented.
Data analysis. To analyze the effect of statistical meth-
odology on the interpretation of the results, data from a
population-based study of the cost of AAA repair with OR
and EVAR8 were used. The study, which aimed to analyze
cost differences between elective OR and EVAR in a pop-
ulation-based setting, included 109 patients who under-
went elective AAA repair during a 5-year period in Uppsala
County in Sweden, comprising 58 with OR and 51 with
EVAR. Cost data on preoperative, perioperative, and post-
operative care, including a mean 2.5 years of follow-up,
were gathered for all patients.
Distribution of the cost data was displayed in box-and-
whisker plots as well as histograms of the original data, after
Fig 1. Schematic histograms illustrate the relationship o
a skewed distribution.
Table I. Description of statistical methods
Method
Student t test A parametric significance test for the eq
distribution of data. In cases of reaso
be disregarded. If the data are substa
misleading results.10
Mann-Whitney U test
(Wilcoxon rank-
sum test)
A nonparametric significance test for as
the same distribution. The Mann-Wh
distribution of data. The test is robu
The Mann-Whitney U test is general
Logarithmic
transformation
Skewed data can be mathematically tran
statistical tests that assume normality
for positively skewed distributions. T
making the interpretation of the resu
Bootstrap simulation A method to simulate a normal distribu
observations is resampled through ra
observation is replaced and is thus at
level, an infinite number of resamplin
interval) often converges reasonably
are normally distributed and can be u
approximated using the 2.5 and 97.5
confidence interval does not become
of resamplings can not be used to malogarithmic transformation of data and after bootstrap sim-ulation of the mean value.9 Medians, means, and confi-
dence intervals were calculated for patients who had under-
gone OR and EVAR. The two groups were compared
statistically using four different methods (Table I; Fig 2), as
suggested by the literature review (Table II).
Statistical evaluation of the data was achieved with
computer software packages Stata 9 (StataCorp LP, Col-
lege Station, TX) for bootstrap analysis and SPSS 14.0
(SPSS, Chicago, IL) for all other statistical analysis. All
costs are presented in Euro 2006 values (€1  US$ 1.3).
RESULTS
Review of studies comparing cost of OR and EVAR
for AAA. We identified 11 articles8,11-20 that assessed the
cost of EVAR for AAA treatment compared with OR (Table
II). One presented median cost data,12 and 10 presented
mean cost data.8,11,13-20 Skewedness of cost data and its effect
n and median values to the total in (A) a normal and (B)
Description
of the means of two populations. The t test assumes normal
large data sets, the prerequisite of normally distributed data may
y nonnormal and the sample size is small, the t test can give
g whether two independent samples of observations come from
U test is based on ranking of data and does not assume normal
utliers but has less statistical power than parametric methods.
sented with median values.10
ed to a more normal distribution, which enables the use of
t test). Logarithm transformation is a commonly used technique
tistical inference calculation is based on the transformed scale,
mplex.10
of the mean value of a skewed data set (Fig 2). A data set with N
selection N times. After each randomization, the selected
ame risk of being reselected at each randomization. At a formal
e performed. In practice, the value of interest (eg, confidence
a thousand resamplings. The mean values from the resamplings
n statistical analysis. The 95% confidence interval of the mean is
entiles of the simulated data. It is important to note that the
wer with an increasing number of resamplings (ie, the number
late data towards a higher significance).9f meauality
nably
ntiall
sessin
itney
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narroon statistical analysis was discussed in three reports,8,14,15 and
Fig 2. Schematic presentation shows the bootstrap simulation technique.
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between 2003 and 2008, and methods for presentation and statistical analysis of cost data
First author, year
Presentation of data Statistical method
SignificanceAverages Distribution t Test MW U test Bootstrap LT None
Tarride,11 2008 Mean ___ X At 5% level
Lesperance,12 2008 Median IQR X P
Mani,8 2008 Mean Range, SD,
histogram
X P
Hynes,13 2007 Mean — X ___
Prinssen,14 2007 Mean 95% CI Xa ___
Visser,15 2006 Mean Range, 95% CI,
histogram
Xb Xb Xb P
EVAR trial,16 2005 Mean Standard error Xc ___
Hayter,17 2005 Mean excluding
extreme
casesd
___ X P
Rosenberg,18 2005 Mean excluding
extreme
casesd
SEM X P
Watson,19 2004 Mean ___ X ___
Dryjski,20 2003 Mean ___ X ___
CI, Confidence interval; IQR, interquartile range; LT, log transformation; MW, Mann-Whitney; SD, standard deviation; SEM, standard error of the mean.
aCost difference with 95% confidence interval calculated with bootstrap simulation.
bComparison of cost based on P value with the Mann-Whitney U test. The 95% confidence interval for total cost was calculated with bootstrap simulation.
Natural logarithm of total cost was used in univariate analysis to identify factors with significant influence on cost.
cStandard error of cost difference was calculated with bootstrap simulation.
dExtreme cases were defined as cost 3 SDs above mean; however, the SD of cost was not given.
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Volume 51, Number 1 Mani et al 151two articles excluded cases with extreme cost.17,18 Three
studies discussed the cost of specific subgroups, such as
patients with complications vs patients without complica-
tions, and their effect on total cost,11,17,20 but only one
study specifically discussed the effect of outlier values on the
results.18 Distribution of cost data was visualized with
histograms in two reports8,15 and with cost-effect plots in
two reports.11,14 A variety of methods were used for infer-
ential statistics (Table II). Only one study analyzed differ-
ences in cost of treatment between OR and EVAR with
several separate statistical methodologies,15 but there was
no discussion on the effect of the statistical methodology
on results of cost analysis.
Effect of statistical methodology on interpretation
of cost data: Analysis of data from a population-based
study. All original cost data for AAA repair were highly
skewed, with numerous extreme values, as visualized in
box-and-whisker plots and histograms (Fig 3; Table III).
Histograms of cost data after logarithmic transformation
and bootstrap simulation are presented in Fig 4. Median
Fig 3. Box-and-whisker plots and histograms of the cos
and endovascular repair (EVAR) using a population-bas
(D) postoperative cost. In the box-and-whisker plots (
(IQR; left line is the lower quartile [Q1], middle line is t
indicate the smallest and largest non-outlier observations
indicate mild outlier (1.5-3 IQR belowQ1 or above Q3)
or above Q3). In the histograms (right in each figure) sta
interval. The full line indicates the mean; dashed lines ind
in each interval.cost was consistently lower thanmean cost for preoperative,perioperative, and postoperative cost for OR and EVAR
(Table III). Mean and median values pointed in different
directions in terms of what treatment strategy was least
costly in three of four parameters: median cost was lower
for OR compared with EVAR in parameters of total cost,
perioperative cost, and postoperative cost; whereas, the
mean value was lower for EVAR in same parameters.
To test for the effect of extreme cost values in the data
set, mean values were calculated when excluding the only
patient with a mean total cost of treatment 3 standard
deviations above the overall average. The patient was a
73-year-old man with a 50-mm infrarenal aneurysm who
underwent OR. The extremely high cost resulted from
perioperative problems, postoperative hemorrhage, and
very long intensive care period. Exclusion of this patient
lowered mean total cost of OR by 8% to €27,525 and the
mean perioperative cost for OR by 10% to €22,161.
Results of inferential statistics with four different meth-
ods for these parameters are presented in Table III. The
values for P were homogenous irrespective of test method
bdominal aortic aneurysm repair with open repair (OR)
dy8. (A) total, (B) preoperative, (C) perioperative, and
each figure), the box indicates the interquartile range
edian, right line is the upper quartile [Q3]); the whiskers
in 1.5 IQR below Q1 or above Q3. The black circles (●)
asterisk (*) shows an extreme outlier (3 IQR belowQ1
ndicate the number of observations (N) in a specific cost
the 95% confidence interval.N,Number of observationst of a
ed stu
left in
he m
with
. The
ples i
icatefor the parameter of preoperative cost. Large variations in P
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other three parameters, and in the parameter postoperative
cost, two test methods indicated a highly significant cost
difference between OR and EVAR, with P  .001;
whereas, two other methods did not indicate any signifi-
cance at all, with P  .901 and P  .209.
DISCUSSION
The present report visualizes the challenges in the
interpretation of health economic cost data. Conclusions
drawn from cost analysis are highly dependent on how the
data are presented and the statistical methodology used to
Table III. Cost of open and endovascular treatment for e
Cost
OR, € EVAR, €
(n  58) (n  51)
Total cost
Mean 29,786 26,382
Median 19,876 22,183
95% CI
Arithmetic 23,353-36,218 23,140-29,624
Bootstrap 24,648-37,139 23,676-30,017
Pre-op cost
Mean 661 1494
Median 400 1114
95% CI
Arithmetic 363-959 984-2003
Bootstrap 449-1041 1078-2087
Peri-op cost
Mean 24,512 20,484
Median 17,411 18,366
95% CI
Arithmetic 19,041-29,983 18,418-22,550
Bootstrap 20,434-31,127 18,716-22,634
Post-op cost
Mean 4613 4403
Median 308 2588
95% CI
Arithmetic 1826-7399 2546-6262
Bootstrap 2340-7795 2940-6556
CI, Confidence interval; EVAR, endovascular aneurysm repair; MW, Mann
aSignificant P values (.05).
Fig 4. Histograms show the total cost of abdominal
Distribution of original cost data, logarithm of cost da
Number of observations in each interval.test for inferences. This is evident when the various statis-tical methods encountered in the current literature are
applied on one data set.
Overall, cost data for AAA repair were skewed, and
important differences in mean and median values were
observed in most cases, with median values consistently
lower than mean values. Medians are often accepted in
medical research when a data set is small, not normally
distributed, and is distorted by a few samples with ex-
tremely high values. For the economic decision maker,
however, median cost would not be useful. For example, a
budget for a clinic performing 100 elective open AAA
repairs annually based on median cost would result in an
e AAA repair in Euros (€1.00  US $ 1.30)
t Test
Bootstrap MW UMean Log mean
P P P P
.347 .877 .336 .180
.006a .003a .002a .001a
.172 .442 .135 .524
.901 .001a .209 .001a
ney; OR, open repair.
aneurysm repair based on a population-based study.8
d bootstrap simulation of mean cost are presented. N,lectiv
-Whitaortic
ta, anunderestimation of the budget by 30% in the current study
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value is the arithmetic mean. Cost comparison studies
should present the distribution of the data as thoroughly as
possible, for example, with means and confidence intervals
(Table III). Furthermore, to allow the reader to appraise
the whole data set— including outliers— data can prefera-
bly be visualized in histograms or box-and-whisker plots
(Fig 3).
The management of outliers in cost studies is complex.
The review indicated two studies where extreme cases were
excluded by cost value alone.17,18 In the present report,
exclusion of one case with extreme cost due to complica-
tions resulted in an 8% to 10% lower cost for the OR group.
Unexpected clinical complications happen with certain reg-
ularity; therefore, such cases should probably be included in
cost calculations. Most of the cases that were excluded
because of extreme cost in the reviewed studies17,18 were
from the OR group. It could be assumed that OR is more
prone to complications requiring reoperations and costly
intensive care, thus producing a higher rate of cases with
extreme cost. Exclusion of the complicated cases from cost
calculations for AAA treatment would in that case errone-
ously favor OR. It should, however, be noted that the effect
of extreme cases may be over estimated in studies with small
samples. In addition, outliers in nonrandomized settings
may be clustered in one treatment group due to patient
selection, for example, selection of patients with complex
aneurysm anatomy to OR rather than EVAR.8 Direct com-
parison of cost is hazardous in such situations.
No optimal technique exists for inferential testing of
cost data,3 and the cost comparison in this article under-
lines the risks of excessive use of P values in health
economics. As a matter of fact, P values tend to be more
dependent on the statistical method used than on the
underlying cost estimates they are testing (Table III). We
tested the differences in cost between OR and EVAR with
four established statistical methods (Table I). All of these
techniques have previously been used in the cost comparison
studies on AAA repair identified in the review (Table II).
One study reported mean values for cost but tested the
differences in mean cost with the nonparametric Mann-
WhitneyU test.15 As shown in the analysis of postoperative
cost in the present study, this can be very misleading (Table
III). The Mann-Whitney U test indicated a significant
difference in cost of postoperative care between OR and
EVAR, although the mean values were practically identical
and the median values were highly different in the opposite
direction. Being free of assumptions about the distribution
of the data, the Mann-Whitney U test is more representa-
tive when presented with medians rather than means and
thus is less applicable to cost comparison studies.
Although transforming cost data to a logarithmic scale
made the distributionmore normalized (Fig 4) and thereby
allowed use of the t test, interpretation of the results based
on transformed data is complex. Furthermore, differences
in logarithmic cost data are of little relevance to the health
economist. Differences in mean cost may be analyzed with
t test and bootstrap. The t test is generally not regarded asappropriate for skewed data unless the sample size is large.
For cost data specifically, Thompson et al3 argued that the
t test may be a relevant estimation of P value and that this
should be verified with bootstrap. P values calculated with
these two methods are, however, not always overlapping
(Table III). The two randomized trials included in the
review both used bootstrap to compare costs.14,16
From this discussion, it is obvious that focus on a
specific P-value limit (eg, P  .05) can give a false sense of
security in terms of assuming significant differences be-
tween two groups. P values depend on methodology, es-
pecially in skewed cost data. Their role is solely to estimate
the risk of chance explaining the difference between two
groups. P values do not reflect effect size, and even a highly
significant P value can be irrelevant in practice if the quan-
titative difference it refers to is small. In this case, the €200
difference in postoperative cost between OR and EVAR
can be regarded as irrelevant in relation to the overall
treatment cost of €26,000 to €29,000, regardless of signif-
icance.
The clinical importance of a difference in cost is better
presented with mean values and confidence intervals or
with an indication of the difference in cost as a percentage
of the total cost. Another often-encountered problem in
cost studies is that they are based on patient data from
clinical trials. Sample sizes in these studies are often based
on clinical outcomes, while cost is a secondary outcome. A
power calculation can be helpful to determine the cost-
difference possible to detect within a clinical trial.
To abstain from inferential statistics is an alternative
that is often disregarded in current medical research where
there is still a strong focus on P values and statistical tests
despite a well-underpinned notion that they cannot form
the base of scientific inference and medical decision
making.21 Presenting the original data and their distri-
bution may give the reader a more accurate understanding
of the similarities and differences in cost than focusing on P
values alone. A problem, however, is that data presented
without inferential statistics are often seen with skepticism
in medical research and may result in difficulties in publish-
ing the results. Even if P values are presented, a sounder
interpretation may follow from playing down the impor-
tance of chance and focusing more on evaluating the valid-
ity of the study (ie, evaluating bias and confounding) and
discuss the quantitative estimates and the confidence inter-
vals.21
When choice of statistical methodology is not obvious,
such as in this form of cost analysis, an alternative can be to
sensitivity test the statistical significance of differences in
cost with several inferential methods. This would be a
complement to the current practice of sensitivity analysis in
economic evaluations.
When data from the population-based study were inter-
preted according to this discussion, we could conclude that
the total cost of AAA repair was similar for OR and EVAR
when mean values and their distributions were compared
(Table III; Fig 3).8 This finding was also robust when tested
with several inferential statistical methods. Analysis of postop-
value
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sults (Table III). However, the most relevant values (means
and confidence intervals) and themost powerful test methods
(bootstrap and t test) did not indicate any difference in post-
operative cost between OR and EVAR.
CONCLUSIONS
Analysis and interpretation of cost data can be challeng-
ing. An understanding of the specific qualities of cost data
and the economic perspective in which these data are used
is important. Conclusions of health economic reports on
the cost of treatment modalities can be highly dependent
on how data are presented and the statistical methodology
used. A high degree of openness when presenting cost data
in medical reports is desirable to avoid misleading conclu-
sions. Five principles for analysis of cost data are suggested
in Table IV.
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